Question 1

Who is Lawrence J. Hineline?

Accepted Answer

Lawrence J. Hineline serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 135 insider transactions totaling $35.8M over their tenure at the company.

Question 2

What is Lawrence J. Hineline's role at Intra-Cellular Therapies, Inc.?

Accepted Answer

Lawrence J. Hineline holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.

Question 3

Is Lawrence J. Hineline buying or selling ITCI stock?

Accepted Answer

Lawrence J. Hineline has shown a selling trading pattern, with $0 in total purchases and $35.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Lawrence J. Hineline's largest insider transactions?

Accepted Answer

The largest transaction by Lawrence J. Hineline was on Jun 14, 2023, when they sold $2.8M worth of ITCI shares. This transaction involved 44,035 shares at $64.37 per share.

Question 5

What is Lawrence J. Hineline's trading accuracy?

Accepted Answer

Lawrence J. Hineline has a Personal Accuracy Score of 79/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Lawrence J. Hineline associated with?

Accepted Answer

Lawrence J. Hineline has filed Form 4 transactions for 1 different company. Their primary association is with Intra-Cellular Therapies, Inc. (ITCI), where they serve as Executive.

Question 7

How much ITCI stock does Lawrence J. Hineline own?

Accepted Answer

Lawrence J. Hineline currently owns 29 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Lawrence J. Hineline's equity in Intra-Cellular Therapies, Inc.?

Accepted Answer

Lawrence J. Hineline's equity position in Intra-Cellular Therapies, Inc. consists of 29 shares valued at approximately $0. As Executive, they have executed 135 insider transactions, with $0 in purchases and $35.8M in sales.

Question 9

Where can I find Lawrence J. Hineline's SEC Form 4 filings?

Accepted Answer

All of Lawrence J. Hineline's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence J. Hineline has 135 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..

Question 10

What is Lawrence J. Hineline's net worth from ITCI?

Accepted Answer

Based on their current ITCI stock holdings, Lawrence J. Hineline has equity worth approximately $0 in Intra-Cellular Therapies, Inc.. This value is based on 29 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Mar 11, 2024	ITCI	$73.2K	Sale	1,100	$66.54	Planned
Mar 11, 2024	ITCI	$297.5K	Sale	4,475

Lawrence J. Hineline

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Lawrence J. Hineline Trading Summary

How Much ITCI Stock Does Lawrence J. Hineline Own?

Is Lawrence J. Hineline Buying or Selling ITCI?

Lawrence J. Hineline's Recent Stock Transactions

Frequently Asked Questions

Track Lawrence J. Hineline's Trades